Simultaneous pathway engagement of translation in astrocytes, circadian rhythm in GABAergic neurons and cytoskeleton in glutamatergic neurons precede electroencephalographic changes in neurodegenerative prion disease
Lech KaczmarczykiD, Melvin Schleif, Lars Dittrich, Rhîannan H. WilliamsiD, Maruša KodermaniD, Vikas BansaliD, Ashish RajputiD, Theresa Schulte, Maria JonsoniD, Clemens Krost, Fabio J. Testaquadra, Stefan BonniD, Walker S. JacksoniD
Abstract
Selective vulnerability is an enigmatic feature of neurodegenerative diseases (NDs), whereby a widely expressed protein causes lesions in specific brain regions and cell types. This selectivity may arise from cells possessing varying capacities to regain proteostasis when stressed by cytotoxic protein conformers. Using the RiboTag method in mice, translational responses of five neural subtypes to acquired prion disease (PrD) were measured. Pre-onset and disease onset timepoints were chosen based on longitudinal electroencephalography (EEG) that revealed a gradual increase in theta power between 10- and 18-weeks after prion injection, resembling a clinical feature of human PrD. At disease onset, marked by significantly increased theta power and histopathological lesions, mice had pronounced translatome changes in all five cell types despite having a normal outward appearance. Remarkably, at a pre-onset stage, prior to EEG and neuropathological changes, we found that 1) translatomes of astrocytes indicated a sharply reduced synthesis of ribosomal and mitochondrial components, 2) excitatory neurons showed increased expression of cytoskeletal genes, and 3) inhibitory neurons revealed reduced expression of circadian rhythm network genes. Further assessment for the role of circadian rhythms using a jet lag paradigm modestly exacerbated disease. These data demonstrate that early translatome responses to neurodegeneration emerge prior to other signs of disease and are unique to different cell types. Therapeutic strategies may need to target multiple pathways, each in specific populations of cells, early in the disease process.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 24
- FWCI
- 1.88
- Field percentile
- top 13%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Prions induce minor genome-wide translational changes in neurons compared to glia
Claudia Scheckel, Marigona Imeri, … Adriano Aguzzi·eLifePeer-reviewed·Sep 22, 2020
- Trazodone rescues dysregulated synaptic and mitochondrial nascent translatomes in prion neurodegeneration
Héctor Albert‐Gascó, Heather Smith, … Giovanna R. Mallucci·bioRxiv·Jun 5, 2023
- Loss of region-specific glial homeostatic signature in prion diseases
Natallia Makarava, Jennifer C. Chang, … Ilia V. Baskakov·bioRxiv·Oct 30, 2019
- A glial circadian gene expression atlas reveals cell type and disease-specific reprogramming in response to amyloid pathology or aging.
Patrick W. Sheehan, Stuart B. Fass, … Erik S. Musiek·Nature NeurosciencePeer-reviewed·Oct 23, 2025
- Genome-wide transcriptomics identifies an early preclinical signature of prion infection
Silvia Sorce, Mario Nuvolone, … Adriano Aguzzi·PLoS PathogensPeer-reviewed·Jun 29, 2020
- Glial activation in prion diseases is strictly nonautonomous and requires neuronal PrPSc
Asvin KK Lakkaraju, Silvia Sorce, … Adriano Aguzzi·bioRxiv·Jan 3, 2021